Craig C. Hopkinson insider trades

Open-market stock purchases and sales by Craig C. Hopkinson, EVP R&D, Chief Medical Officer at Alkermes plc., from SEC Form 4 filings since Feb 16, 2018.

Recent trades

DateStockTradeValue
Sep 1, 2026ALKS Alkermes plc.Sold$423K
Sep 1, 2026ALKS Alkermes plc.Bought (not open market)—
Aug 3, 2026ALKS Alkermes plc.Bought (not open market)—
Aug 3, 2026ALKS Alkermes plc.Sold$437K
Aug 3, 2026ALKS Alkermes plc.Bought (not open market)—
Jul 1, 2026ALKS Alkermes plc.Sold$427K
Jul 1, 2026ALKS Alkermes plc.Sold$36.5K
Jul 1, 2026ALKS Alkermes plc.Bought (not open market)$96.7K
Jul 1, 2026ALKS Alkermes plc.Bought (not open market)—
Jun 1, 2026ALKS Alkermes plc.Sold$375K
Jun 1, 2026ALKS Alkermes plc.Bought (not open market)—
May 1, 2026ALKS Alkermes plc.Sold$301K
May 1, 2026ALKS Alkermes plc.Bought (not open market)—
Apr 1, 2026ALKS Alkermes plc.Bought (not open market)—
Apr 1, 2026ALKS Alkermes plc.Sold$320K
Mar 2, 2026ALKS Alkermes plc.Sold$267K
Mar 2, 2026ALKS Alkermes plc.Bought (not open market)—
Mar 2, 2026ALKS Alkermes plc.Bought (not open market)—
Mar 2, 2026ALKS Alkermes plc.Bought (not open market)—
Feb 26, 2026ALKS Alkermes plc.Sold (not open market)$93.7K
Feb 26, 2026ALKS Alkermes plc.Bought (not open market)—
Feb 23, 2026ALKS Alkermes plc.Sold (not open market)$110K
Feb 23, 2026ALKS Alkermes plc.Bought (not open market)—
Feb 19, 2026ALKS Alkermes plc.Sold (not open market)$109K
Feb 19, 2026ALKS Alkermes plc.Bought (not open market)—

Companies traded

  • ALKS Alkermes plc.: 30 sales, last Sep 1, 2026
  • ALBO Albireo Pharma, Inc: other filings, last Mar 2, 2023

Get free alerts when Craig C. Hopkinson files a new trade →